Developing a Simple 3-Day Insulin Delivery Device to Meet the Needs of People With Type 2 Diabetes.
Leslie C LillyJulia K MaderJay WarnerPublished in: Journal of diabetes science and technology (2018)
The collective data from the HFT, adhesive, and clinical studies demonstrated that the device provides a method of insulin delivery that overcomes barriers to injectable insulin, meets the needs of the user, and achieves glycemic control.